Mood Alterations in the Patients With Non-Muscle Invasive Bladder Cancer Treated With BCG

RecruitingOBSERVATIONAL
Enrollment

42

Participants

Timeline

Start Date

March 21, 2023

Primary Completion Date

September 30, 2026

Study Completion Date

September 30, 2028

Conditions
Non-Muscle Invasive Bladder Cancer
Interventions
OTHER

Questionnaires

Participants will be given the Zung Self-Rating Anxiety Scale and Zung Self-Rating Depression Scale to complete prior to each induction intravesical treatment and prior to 3-month follow-up appointments.

OTHER

Daily Mood Diaries

Participants will be given daily mood diaries to complete during their 6-week induction intravesical treatment, 3-week maintenance treatment course, and between 3-month follow-up appointments.

OTHER

Urine Specimen Collection

Urine collections from patients will occur prior to each induction intravesical treatment and at 3-month follow-up cystoscopy appointments. An at home urine collection may occur 6 hours post intravesical treatment.

OTHER

Research Blood Draw

Blood collections will occur prior to first intravesical treatment, prior to fourth intravesical treatment, and each 3-month cystoscopy as indicated by the participant's treatment course.

OTHER

Utilize excess tissue from a standard of care procedure

Participants may indicate permission to provide excess tissue from a clinically indicated procedure for research purposes.

Trial Locations (1)

20016

RECRUITING

Sibley Memorial Hospital, Washington D.C.

All Listed Sponsors
lead

Johns Hopkins University

OTHER